Vaccinex, Inc. Cost of Revenue
Vaccinex, Inc. (VCNX) reported Cost of Revenue of $2.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2022-03-31
- Vaccinex, Inc. cost of revenue for the quarter ending 2020-12-31 was $0.00.
- Vaccinex, Inc. cost of revenue for the quarter ending 2020-09-30 was $2.00K, a 75.00% decline year-over-year.
- Vaccinex, Inc. cost of revenue for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Vaccinex, Inc. cost of revenue for the quarter ending 2019-09-30 was $8.00K, a 96.75% decline year-over-year.
- Vaccinex, Inc. cost of revenue for fiscal 2020 was $2.00K, a 98.99% decline from fiscal 2019.
- Vaccinex, Inc. cost of revenue for fiscal 2019 was $199.00K, a 80.74% decline from fiscal 2018.
- Vaccinex, Inc. cost of revenue for fiscal 2018 was $1.03M, a 545.63% increase from fiscal 2017.
- Vaccinex, Inc. cost of revenue for fiscal 2017 was $160.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $2.00K derived: sum of 2 quarters · filed 2022-03-31 | $2.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.00K 10-Q · filed 2021-11-08 | $2.00K 10-Q · filed 2021-11-08 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $8.00K derived: sum of 2 quarters · filed 2021-03-31 | $24.00K derived: sum of 3 quarters · filed 2021-03-31 | $199.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $8.00K 10-Q · filed 2020-11-13 | $24.00K derived: sum of 2 quarters · filed 2020-11-13 | $199.00K 10-Q · filed 2020-11-13 | $500.00K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $16.00K 10-Q · filed 2020-08-14 | $191.00K 10-Q · filed 2020-08-14 | $492.00K derived: sum of 3 quarters · filed 2020-08-14 | $738.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $175.00K 10-Q · filed 2020-05-14 | $476.00K derived: sum of 2 quarters · filed 2020-05-14 | $722.00K derived: sum of 3 quarters · filed 2020-05-14 | $968.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $547.00K derived: sum of 2 quarters · filed 2020-03-09 | $793.00K derived: sum of 3 quarters · filed 2020-03-09 | $1.03M 10-K · filed 2020-03-09 |
| 2018-09-30 | $246.00K 10-Q · filed 2019-11-12 | $492.00K derived: sum of 2 quarters · filed 2019-11-12 | $732.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $246.00K 10-Q · filed 2019-08-14 | $486.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $240.00K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $160.00K 10-K · filed 2019-03-13 |